InvestorsHub Logo
Followers 11
Posts 819
Boards Moderated 0
Alias Born 07/24/2015

Re: shell3 post# 164

Friday, 07/01/2016 9:11:20 AM

Friday, July 01, 2016 9:11:20 AM

Post# of 16696
Wednesday's event was billed as Breathtec's "Investor Relations Day". Private meetings with mgt were also available for investment professionals after the presentation. Having Canada's lead biotechnology person attending was impressive however, any positive or stimulating news would have rallied volume (similar to when Dr. Boock spoke at PITTCON earlier this year), but fell short of expectations.

Also, Im slightly confused with Technion's relationship with BTH/CF and Yost Research's role. Correct me if I'm wrong. In layman's terms, Technion is providing a catalog of known biomarkers for various ailments. This technology is to interact and decipher breath samples following the FAIMS/MS process?